BDBM516546 (2S)-1-[(2R)-2-phenyl-2- (pyrrolidin-1-yl)acetyl]-N-(4-{5- [({(2S)-1-[(2R)-2-phenyl-2- (pyrrolidin-1-yl)acetyl] pyrrolidin-2-yl}carbonyl)amino]- 1H-indol-2-yl}phenyl) pyrrolidine-2-carboxamide::US11053243, Example 45

SMILES O=C(Nc1ccc(-c2cc3cc(NC(=O)[C@@H]4CCCN4C(=O)[C@@H](c4ccccc4)N4CCCC4)ccc3[nH]2)cc1)[C@@H]1CCCN1C(=O)[C@@H](c1ccccc1)N1CCCC1

InChI Key InChIKey=LBXKXAKXTDJHJJ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 516546   

TargetGenome polyprotein(HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 516546BDBM516546(US11053243, Example 45 | (2S)-1-[(2R)-2-phenyl-2- ...)
Affinity DataEC50:  0.0200nMAssay Description:Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent